OraSure Technologies Past Earnings Performance
Past criteria checks 1/6
OraSure Technologies's earnings have been declining at an average annual rate of -0.7%, while the Medical Equipment industry saw earnings growing at 2% annually. Revenues have been growing at an average rate of 26.1% per year. OraSure Technologies's return on equity is 12.5%, and it has net margins of 13.2%.
Key information
-0.7%
Earnings growth rate
-3.8%
EPS growth rate
| Medical Equipment Industry Growth | 4.3% |
| Revenue growth rate | 26.1% |
| Return on equity | 12.5% |
| Net Margin | 13.2% |
| Next Earnings Update | 08 May 2024 |
Recent past performance updates
Recent updates
Revenue & Expenses BreakdownBeta
How OraSure Technologies makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
| Date | Revenue | Earnings | G+A Expenses | R&D Expenses |
|---|---|---|---|---|
| 31 Dec 23 | 405 | 54 | 92 | 33 |
| 30 Sep 23 | 453 | 49 | 101 | 35 |
| 30 Jun 23 | 480 | 43 | 111 | 36 |
| 31 Mar 23 | 475 | 29 | 115 | 38 |
| 31 Dec 22 | 387 | -17 | 117 | 36 |
| 30 Sep 22 | 328 | -43 | 118 | 37 |
| 30 Jun 22 | 265 | -64 | 115 | 36 |
| 31 Mar 22 | 243 | -47 | 107 | 34 |
| 31 Dec 21 | 234 | -23 | 95 | 34 |
| 30 Sep 21 | 233 | -11 | 89 | 36 |
| 30 Jun 21 | 227 | 5 | 80 | 35 |
| 31 Mar 21 | 199 | -4 | 79 | 34 |
| 31 Dec 20 | 172 | -15 | 77 | 31 |
| 30 Sep 20 | 158 | -14 | 74 | 27 |
| 30 Jun 20 | 146 | -2 | 72 | 23 |
| 31 Mar 20 | 156 | 13 | 67 | 21 |
| 31 Dec 19 | 155 | 17 | 65 | 20 |
| 30 Sep 19 | 150 | 25 | 73 | 18 |
| 30 Jun 19 | 159 | 20 | 70 | 17 |
| 31 Mar 19 | 161 | 19 | 69 | 17 |
| 31 Dec 18 | 182 | 20 | 69 | 16 |
| 30 Sep 18 | 177 | 17 | 57 | 16 |
| 30 Jun 18 | 174 | 15 | 57 | 15 |
| 31 Mar 18 | 174 | 16 | 58 | 14 |
| 31 Dec 17 | 166 | 31 | 58 | 13 |
| 30 Sep 17 | 145 | 31 | 60 | 10 |
| 30 Jun 17 | 135 | 31 | 59 | 10 |
| 31 Mar 17 | 126 | 30 | 57 | 10 |
| 31 Dec 16 | 123 | 20 | 58 | 10 |
| 30 Sep 16 | 125 | 17 | 58 | 11 |
| 30 Jun 16 | 123 | 12 | 61 | 10 |
| 31 Mar 16 | 122 | 11 | 62 | 10 |
| 31 Dec 15 | 120 | 8 | 61 | 11 |
| 30 Sep 15 | 116 | 1 | 63 | 12 |
| 30 Jun 15 | 114 | 1 | 61 | 13 |
| 31 Mar 15 | 110 | 1 | 62 | 12 |
| 31 Dec 14 | 106 | -5 | 65 | 12 |
| 30 Sep 14 | 107 | 4 | 66 | 10 |
| 30 Jun 14 | 103 | 1 | 65 | 10 |
| 31 Mar 14 | 101 | -7 | 67 | 9 |
| 31 Dec 13 | 99 | -11 | 69 | 10 |
| 30 Sep 13 | 92 | -23 | 68 | 11 |
| 30 Jun 13 | 90 | -24 | 67 | 11 |
Quality Earnings: EP3 has a large one-off loss of $21.4M impacting its last 12 months of financial results to 31st December, 2023.
Growing Profit Margin: EP3 became profitable in the past.
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: EP3's earnings have declined by 0.7% per year over the past 5 years.
Accelerating Growth: EP3 has become profitable in the last year, making the earnings growth rate difficult to compare to its 5-year average.
Earnings vs Industry: EP3 has become profitable in the last year, making it difficult to compare its past year earnings growth to the Medical Equipment industry (-9.8%).
Return on Equity
High ROE: EP3's Return on Equity (12.5%) is considered low.